An update from Better Therapeutics, Inc. (BTTX) is now available.
Better Therapeutics, Inc. is set to be delisted from the Nasdaq following their voluntary request during a hearing on March 14, 2024, after previously failing to meet minimum bid price requirements. Trading of the company’s stock will be suspended from March 18, 2024. In a significant shift, the company’s board saw the resignation of seven directors, and top officers were terminated, including the CEO and President. Craig R. Jalbert has been appointed as the new CEO, President, and sole board member, bringing his expertise in managing distressed businesses to oversee the company’s wind-down phase.
See more data about BTTX stock on TipRanks’ Stock Analysis page.
